Sabilla, Narcisa .
HRN: 23-92-19 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/05/2023
CEFUROXIME 500MG (TAB)
12/05/2023
12/12/2023
PO
500 Mg
BiD
UTI
Checking Final Appropriateness